Trials / Sponsors / BioPorto Diagnostics
BioPorto Diagnostics
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | Establishment of ProNephro AKI (NGAL) Cut Off Value for Risk Assessment of Moderate to Severe Acute Kidney Inj Acute Kidney Injury | — | 2024-10-28 |
| Unknown | The NGAL Test™ As An Aid in the Risk Assessment for AKI Stage II and III in an Intensive Care Population Kidney Injury | — | 2017-03-01 |
| Completed | NGAL As An Aid for the Diagnosis of Acute Kidney Injury in Intensive Care Acute Kidney Injury | — | 2014-02-01 |